Taken together, our study provides experimental evidence for increased nuclear expression of p53 in sebaceous glands and skin of acne patients after oral isotretinoin treatment and substantiates that enforced p53-FoxO signalling causes all desired and adverse effects of systemic isotretinoin therapy. The gene discussed is TP53; the disease is acne.